Bisphenol a induces steatosis in HepaRG cells using a model of perinatal exposure

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Environmental Toxicology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/tox.22301PMID 27322340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure

  2018cited by this paper
• Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development

  2018cited by this paper
• 急性腎障害におけるestrogen‐related receptor αの役割に関する検討

  2017cited by this paper
• Bisphenol A sulfonation is impaired in metabolic and liver disease.

  2016cited by this paper
• A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

  2016cited by this paper
• SLC13A5 Is a Novel Transcriptional Target of the Pregnane X Receptor and Sensitizes Drug-Induced Steatosis in Human Liver

  2015cited by this paper
• Pharmacokinetics of bisphenol A in humans following a single oral administration.

  2015cited by this paper
• Low doses of bisphenol A stimulate the proliferation of breast cancer cells via ERK1/2/ERRγ signals.

  2015cited by this paper
• ARYL HYDROCARBON RECEPTOR DEFICIENCY PROTECTS MICE FROM DIET-INDUCED ADIPOSITY AND METABOLIC DISORDERS THROUGH INCREASED ENERGY EXPENDITURE

  2015cited by this paper
• In utero bisphenol A concentration, metabolism, and global DNA methylation across matched placenta, kidney, and liver in the human fetus.

  2015cited by this paper
• Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease.

  2014influential reference
• Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet.

  2014cited by this paper
• Bisphenol A and cardiometabolic risk factors in obese children.

  2014influential reference
• Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non‐alcoholic steatohepatitis (NASH)?

  2014cited by this paper
• Estrogen‐related receptor γ is an in vivo receptor of bisphenol A

  2014cited by this paper
• Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver

  2014cited by this paper
• Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study.

  2014cited by this paper
• Modulation of metabolizing enzymes by bisphenol a in human and animal models.

  2014cited by this paper
• Bisphenol A exposure and associations with obesity among adults: a critical review

  2014influential reference
• Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives.

  2014cited by this paper
• Comparative analysis of human CYP3A4 and rat CYP3A1 induction and relevant gene expression by bisphenol A and diethylstilbestrol: implications for toxicity testing paradigms.

  2013influential reference
• Pregnane X receptor (PXR) at the crossroads of human metabolism and disease.

  2013cited by this paper
• Direct effects of Bisphenol A on lipid homeostasis in rat hepatoma cells.

  2013cited by this paper
• Fetal Liver Bisphenol A Concentrations and Biotransformation Gene Expression Reveal Variable Exposure and Altered Capacity for Metabolism in Humans

  2013cited by this paper
• Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease

  2013cited by this paper
• Bisphenol A and human health: a review of the literature.

  2013cited by this paper
• Optimization of the HepaRG cell model for drug metabolism and toxicity studies.

  2012influential reference
• Orphan Nuclear Receptor Estrogen-Related Receptor γ (ERRγ) Is Key Regulator of Hepatic Gluconeogenesis*

  2012cited by this paper
• Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells.

  2012cited by this paper
• Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents.

  2012influential reference
• Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERRγ

  2012cited by this paper
• The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.

  2012cited by this paper
• Bisphenol A and Its Analogues Activate Human Pregnane X Receptor

  2012influential reference
• Low doses of bisphenol a induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver

  2012cited by this paper
• The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human

  2012cited by this paper
• Estrogen-related receptor gamma modulates energy metabolism target genes in human trophoblast.

  2012cited by this paper
• Differences in Early Acetaminophen Hepatotoxicity between Obese ob/ob and db/db Mice

  2012cited by this paper
• Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

  2012cited by this paper
• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

  2012cited by this paper
• Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects.

  2011cited by this paper
• Fetal Origins of Adult Disease

  2011cited by this paper
• Human Fatty Liver Disease: Old Questions and New Insights

  2011cited by this paper
• Hepatic Xenobiotic Metabolizing Enzyme and Transporter Gene Expression through the Life Stages of the Mouse

  2011cited by this paper
• In-vitro oxidation of bisphenol A: Is bisphenol A catechol a suitable biomarker for human exposure to bisphenol A?

  2011cited by this paper
• Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.

  2011cited by this paper
• Fetal origins of adult disease.

  2011cited by this paper
• Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

  2010influential reference
• Bisphenol-A: a new diabetogenic factor?

  2010cited by this paper
• Dose-Response: An International Journal

  2010influential reference
• Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring

  2010cited by this paper
• miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway.

  2010cited by this paper
• Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A

  2010cited by this paper
• Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines.

  2010cited by this paper
• Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression.

  2009cited by this paper
• Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes

  2009cited by this paper
• PXR and CAR in energy metabolism.

  2009cited by this paper
• Three Patterns of Cytochrome P450 Gene Expression during Liver Maturation in Mice

  2009influential reference
• Perinatal Exposure to Bisphenol A Alters Early Adipogenesis in the Rat

  2009cited by this paper
• Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption.

  2009cited by this paper
• Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response.

  2008cited by this paper
• PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics.

  2008influential reference
• Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies

  2008cited by this paper
• Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor.

  2008cited by this paper
• Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.

  2008cited by this paper
• Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

  2007cited by this paper
• Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

  2007cited by this paper
• ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart.

  2007influential reference
• Direct Evidence Revealing Structural Elements Essential for the High Binding Ability of Bisphenol A to Human Estrogen-Related Receptor-γ

  2007cited by this paper
• Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor

  2007influential reference
• Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice.

  2007cited by this paper
• Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity.

  2006cited by this paper
• EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS

  2006cited by this paper
• Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity

  2006influential reference
• Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions.

  2005cited by this paper
• Origin and characterization of a human bipotent liver progenitor cell line.

  2004cited by this paper
• Phase I and II enzyme characterization of two sources of HepG2 cell lines

  2004cited by this paper
• in HepG2 cells

  2003cited by this paper
• Infection of a human hepatoma cell line by hepatitis B virus

  2002cited by this paper
• Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17.

  2001cited by this paper
• Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes.

  2000cited by this paper
• Sex-dependent metabolism of xenobiotics.

  1998cited by this paper
• Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

  1997cited by this paper
• Expression and inducibility of P450 enzymes during liver ontogeny

  1997cited by this paper
• Developmental alteration of the chromatin state at promoter/replication origin region of the aldolase B locus precedes transcriptional activation in the liver.

  1995cited by this paper
• Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene

  1989cited by this paper
• Expression of aldolase isozyme mRNAs in fetal rat liver.

  1984cited by this paper
• Changes in rat alpha 1-fetoprotein and albumin mRNA levels during fetal and neonatal development.

  1980influential reference
• Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies.

  1972cited by this paper
• Fetal Liver

  1967cited by this paper
• Direct Evidence

  1934influential reference
• Environmental Health Environmental Health Bisphenol a and the Risk of Cardiometabolic Disorders: a Systematic Review with Meta-analysis of the Epidemiological Evidence Bisphenol a and the Risk of Cardiometabolic Disorders: a Systematic Review with Meta-analysis of the Epidemiological Evidence

  year unknowninfluential reference

• Impact of Endocrine Disruptors on Key Events of Hepatic Steatosis in HepG2 Cells.

  2025cites this paper
• Consensus on the key characteristics of metabolism disruptors

  2024cites this paper
• The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies

  2024cites this paper
• Hepatoprotective effect of Artemisia Argyi essential oil on bisphenol A‐induced hepatotoxicity via inhibition of ferroptosis in mice

  2023cites this paper
• Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants—A Review

  2023influential citation
• Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs

  2023cites this paper
• Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line.

  2023cites this paper
• 3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments.

  2023cites this paper
• Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease

  2022cites this paper
• Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells

  2022cites this paper
• Bisphenol analogues induced metabolic effects through eliciting intestinal cell heterogeneous response.

  2022cites this paper
• Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells

  2022cites this paper
• In Vitro Models for Studying Chronic Drug-Induced Liver Injury

  2022cites this paper
• SHORT REVIEW ON PROTECTIVE EFFECTS OF POLYPHENOLS AGAINST DISORDERS CAUSED BY BISPHENOLS

  2022cites this paper
• Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients

  2021cites this paper
• The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds

  2020cites this paper
• In vitro evaluation of the hepatic lipid accumulation of bisphenol analogs: A high-content screening assay.

  2020cites this paper
• The influence of polyphenols on metabolic disorders caused by compounds released from plastics - Review.

  2020cites this paper
• AN OMICS BASED APPROACH FOR THE IDENTIFICATION OF BIOMARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE USING IN VITRO MODELS OF HEPATIC STEATOSIS

  2019cites this paper
• Characterization Of Cytosolic Sulfotransferase Expression And Regulation In Human Liver And Intestine

  2019cites this paper
• Mitochondrial Dysfunction Induced by Xenobiotics: Involvement in Steatosis and Steatohepatitis

  2019cites this paper
• Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells

  2018cites this paper
• Large-Scale Modeling Approach Reveals Functional Metabolic Shifts during Hepatic Differentiation.

  2018cites this paper
• Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure

  2018cites this paper
• Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development

  2018cites this paper
• Toxins, Malnutrition, Stress, Infections and Electromagnetic Pollution:Looking about New Perspectives in Development of Diseases

  2016cites this paper
• Mass Spectrometry-Based Quantitative Proteomics for Drug-Metabolizing Enzymes

  2016cites this paper